期刊文献+

乳腺浸润性导管癌患者中Fhit基因的表达及其与雌、孕激素受体表达的相关性 被引量:2

Correlation and clinical significance of Fhit protein,estrogen and progesterone expression in breast cancer
下载PDF
导出
摘要 目的:探讨乳腺浸润性导管癌组织中Fhit基因表达及其与雌激素受体(ER)、孕激素受体(PR)的关系。方法:采用免疫组化SP法检测128例乳腺浸润性导管癌及50例良性增生病变标本中Fhit基因及128例乳腺浸润性导管癌ER、PR的表达情况。结果:Fhit基因在乳腺浸润性导管癌病例中阳性表达率为27.34%(35/128),明显低于其在乳腺腺病中的阳性表达率70.00%(35/50)。差异有统计学意义(P<0.05)。在乳腺癌组织中,Fhit蛋白表达与组织学分级、腋窝淋巴结的转移的差异有统计学意义(P<0.05),与绝经情况、肿瘤长径、TNM分期差异无统计学意义(P>0.05)。通过相关性分析得出Fhit蛋白表达与ER及PR表达相关(P<0.05)。结论:联合检测乳腺癌组织ER、PR和Fhit蛋白的表达对于乳腺癌诊断、肿瘤恶性程度判定及预后有意义。 Objective: To analyze the Fhit gene expression in invasive ductal breast carcinoma and it's relationship between the estrogen receptor (ER) and progesterone receptor (PR). Methods: Taking immunohistochemiatry streptavidin peroxidase (SP) method to detect the Fhit gene expression in 128 cases of invasire ductal breast cancer and 50 cases with benign lesions, and detecting the ER and PR expression in 128 cases ofinvasive ductal breast cancer. Results: The positive rate of Fhit protein in breast cancer tissues was lower than that in benign breast tumor, the difference was statistically significant (P〈0.05). The expression of Fhit protein in breast cacinoma was correlated with the histological grade, lymph node metastasis, the difference was statistically significant (P〈0.05) and independence with tumor size, menopause, TNM stage (P 〉0.05). The rank correlation drawn Fhit protein expression with ER and PR expression associated with statistical significance (P 〈0.05). Conclusion: Fhit protein, ER and PR combined detection may help diagnosis and evaluate the malignant condition, prognosis of breast cacinoma.
出处 《新疆医科大学学报》 CAS 2008年第3期280-282,共3页 Journal of Xinjiang Medical University
关键词 乳腺癌 FHIT 雌激素受体 孕激素受体 免疫组织化学 breast carcinoma Fhit estrogen receptor progesterone receptor immunohistochemistry
  • 相关文献

参考文献6

二级参考文献1

共引文献60

同被引文献39

  • 1王湛博,赵坡,刘梅,李向红.乳腺浸润性导管癌患者中FHIT、Bcl-2、Bax的表达及其临床病理意义[J].中华医学杂志,2006,86(31):2171-2176. 被引量:6
  • 2张浩,僧靖静,赵玉亭,李伟汉.乳癌组织中脆性组氨酸三联体蛋白检测[J].郑州大学学报(医学版),2007,42(1):137-139. 被引量:1
  • 3金春亭,李海军,张林西,李玉珍,范婕,武欣,白美玲.FHIT抑癌基因在乳腺癌组织中的表达缺失[J].河北北方学院学报(医学版),2007,24(1):14-16. 被引量:4
  • 4Ashworth TR. A case of cancer in which cells similar to those in the tumors were seen in the blood after death[J]. Aust Med J, 1869,14:146.
  • 5Paget S. Distribution of secondary growths in cancer of the breast [J]. Lancet, 1889,1:571.
  • 6Jiang Z F,Cristo fanilli M,Shao Z M,et al. Circulating tumor cells predict progression-free and overall survival in Chinese patients with metastatic breast cancer, HER2-positive or triple-negative (CBCSG004) : a multicenter, double-blind, prospective trial [J]. Ann Oncol,2013.
  • 7von Minekwitz G, Untch M, Blohmer JU, et al. De nition and im- pact of pathologiccomplete response on prognosis after neoadju- vant chemotherapy in variousintrinsie breast cancer subtypes[J]. J Clin Oncol, 2012,30 : 1796.
  • 8Aliki Stathopoulou, Anna Gizi, Maria Perraki, et al. Real-Time Quantification of CK-19 mRNA-Positive Ceils in Peripheral Blood of Breast Cancer Patients Using the Lightcycler System[J]. Clini- cal Cancer Research, 2003,9 : 5145.
  • 9De Giorgi,et al. Circulating Tumor Cells and Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Out- come Prediction in Metastatic Breast Cancer[J]. Clin Oncol, 2009, 27(20) :3303.
  • 10Ramadan A, Harouakal, et al. Circulating Tumor Cell Enrich- ment Based on Physieal Properties[J]. Journal Laboratory Auto- mation,2013,18(6) :455.

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部